Company intelligence / Profile preview
Blacksmith Medicines
San Diego, California, United Statesblacksmithmedicines.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Lead program FG‑2101 has completed preclinical toxicology studies with support from NIAID funding. IND-enabling work is ongoing for first-in-class antibacterial agent targeting LpxC. Additional oncology assets are in earlier stages of development
- Therapeutic areas
- OncologyImmunologyInfectious Diseases
- Modalities
- Small molecules (specifically, metalloenzyme inhibitors)
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
Eli Lilly and Company – research collaboration up to $300M value on up to five human metalloenzyme targetsRoche – drug discovery collaborationBasilea Pharmaceutica International Ltd. – strategic partnershipCyteir Therapeutics Inc. – strategic partnershipZoetis LLC – veterinary medicine collaborationCARB-X & NIH/NIAID – non-dilutive federal funding agreements
Beyond the preview
Go deeper on Blacksmith Medicines.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Blacksmith Medicines.